Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02109952 · ClinicalTrials.gov registry record
Biomechanics of Metastatic Defects in Bone
A clinical trial of Cancer Bone and Bone Tumors, sponsored by Beth Israel Deaconess Medical Center.
- Active
- Registry status
- 245
- Enrollment target
- 8
- Study locations
NCT02109952: Active study of Cancer Bone and Bone Tumors, sponsored by Beth Israel Deaconess Medical Center.
NCT02109952 is a study of Cancer Bone and Bone Tumors that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 245 participants. The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02109952, a study of Cancer Bone and Bone Tumors, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 245 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to monitor fracture risk associated with bone tumors in cancer patients. Previous studies from our lab have suggested that it is possible to compute the mechanical strength of bones with tumors using computed tomography (CT) scans, which are like three-dimensional X-ray pictures of the affected bones. The next step in determining the usefulness of this type of strength analysis is to see if we can accurately predict who is at risk for bone fracture and which patients are at high risk of fractures. This non-invasive analysis may help physicians determine the best treatment to reduce the risk of an impending bone fracture in the future.
Conditions Studied
Study Locations (8)
Maryland
- Alvin and Lois Lapidus Cancer Center, Sinai Hospital of Baltimore, Inc - Baltimore
Massachusetts
- Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School - Boston
Minnesota
- Department of Orthopaedic Surgery, University of Minnesota Medical Center - Minneapolis
New York
- Department of Orthopedic Surgery, Upstate Medical University - Syracuse
Rhode Island
- Department of Orthopaedic Surgery, Rhode Island Hospital - Providence
Texas
- Section of Orthopaedic Oncology, University of Texas M. D. Anderson Cancer Center - Houston
West Virginia
- Edwards Comprehensive Cancer Center, Marshall University - Huntington
Quebec
- Department of Orthopaedic Surgery, McGill University Health Centre - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2009-01 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT02109952 still lists
NCT02109952 is an observational study that tracks outcomes without assigning an intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Cancer Bone appearing as the primary indexed condition, and to 0 interventions.
NCT02109952 lists 8 locations in 8 states (Maryland, Massachusetts, Minnesota).
Frequently Asked Questions
What is clinical trial NCT02109952 about?
NCT02109952 is a clinical study titled "Biomechanics of Metastatic Defects in Bone". The purpose of this study is to monitor fracture risk associated with bone tumors in cancer patients. Previous studies from our lab have suggested that it is possible to compute the mechanical strength of bones with tumors using computed tomography (CT) scans, which are like three-dimensional X-ray...
What is the current status of trial NCT02109952?
This trial is currently active not recruiting. The enrollment target is 245 participants. The study started on 2009-01. Estimated completion is 2025-12-31.
What conditions does trial NCT02109952 study?
This clinical trial studies the following conditions: Cancer Bone, Bone Tumors.
Who is sponsoring clinical trial NCT02109952?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02109952 being conducted?
This trial has 8 study locations across Maryland, Massachusetts, Minnesota, New York, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT05446259 · 245 participants
Degenerative Cervical Myelopathy Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia